Evidence map›Paper›PMID 39034365›Full record

ArticleAnnals of surgical oncology2024

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.

Alexa C Glencer, Kerollos Nashat Wanis, Sydnee Brown, Anthony Lucci, Susie X Sun, Taiwo Adesoye, Sarah M DeSnyder, Rachel Layman, Wendy A Woodward, Kelly K Hunt and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexa C GlencerDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Kerollos Nashat WanisDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Sydnee BrownDepartment of Orthopedic Surgery, Baylor College of Medicine, Houston, TX, USA.
Anthony LucciDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Susie X SunDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Taiwo AdesoyeDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Sarah M DeSnyderDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Rachel LaymanDepartment of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Wendy A WoodwardDepartment of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Kelly K HuntDepartment of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Mediget TeshomeDepartment of Surgery, Division of Surgical Oncology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. mteshome@mednet.ucla.edu.ORCID http://orcid.org/0000-0001-8632-0256

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

backgroundInflammatory breast cancer (IBC) is rare and biologically aggressive. We sought to assess diagnostic and management strategies among the American Society of Breast Surgeons (ASBrS) membership. PATIENTS AND

methodsAn anonymous survey was distributed to ASBrS members from March to May 2023. The survey included questions about respondents' demographics and information related to stage III and IV IBC management. Agreement was defined as a shared response by >80% of respondents. In areas of disagreement, responses were stratified by years in practice, fellowship training, and annual IBC patient volume.

resultsThe survey was administered to 2337 members with 399 (17.1%) completing all questions and defining the study cohort. Distribution of years in practice was 26.0% 0-10 years, 26.6% 11-20 years and 47.4% > 20 years. Overall, 51.2% reported surgical oncology or breast fellowship training, 69.2% maintain a breast-only practice, and 73.5% treat < 5 IBC cases/year. Agreement was identified in diagnostic imaging, trimodal therapy, and mastectomy with wide skin excision for stage III IBC. Lack of agreement was identified in surgical management of the axilla; respondents with < 10 years in practice or fellowship training were more likely to perform axillary dissection for cN0-N2 stage III IBC. Locoregional management of stage IV IBC was variable.

conclusionsAmong ASBrS members, there is consensus in diagnostic evaluation, treatment sequencing and surgical approach to the breast in stage III IBC. Differences exist in surgical management of the cN0-2 axilla with uptake of de-escalation strategies. Clinical trials are needed to evaluate oncologic safety of de-escalation in this high-risk population.

Indexed as

ConsensusInflammatory Breast NeoplasmsSelf ReportSocieties, MedicalSurgeonsAdultFemaleFollow-Up StudiesHumansMastectomyMiddle AgedPractice Patterns, Physicians'PrognosisSurgical OncologySurveys and QuestionnairesUnited StatesAmerican Society of Breast SurgeonsInflammatory breast cancerSurgical de-escalationTrimodal therapy

Identifiers

PMID39034365
PMCPMC12396853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.